- Home
- NVS vs SAN Comparison
NVS vs SAN Comparison
Compare NVS & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVS | SAN |
|---|---|---|
| Founded | 1895 | 1857 |
| Country | Switzerland | Spain |
| Employees | 75267 | 186370 |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.5B | 179.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVS | SAN |
|---|---|---|
| Price | $153.37 | $13.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $144.00 | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 8.5M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.16% | 1.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.30 | $34.53 |
| Revenue Next Year | $5.27 | $6.55 |
| P/E Ratio | $23.13 | ★ $11.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $112.34 | $8.19 |
| 52 Week High | $170.46 | $13.78 |
Technical Indicators
Market Signals| Indicator | NVS | SAN |
|---|---|---|
| Relative Strength Index (RSI) | 56.42 | 65.48 |
| Support Level | $149.49 | $11.75 |
| Resistance Level | $154.57 | N/A |
| Average True Range (ATR) | 2.25 | 0.27 |
| MACD | 0.19 | 0.12 |
| Stochastic Oscillator | 85.62 | 88.24 |
Price Performance
Historical ComparisonAbout NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
About SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.